Population
249 consecutive patients undergoing percutaneous coronary intervention with sirolimus-eluting stents
Design
Cohort
Follow-up
5 years
Authors
Loading...
Late TLR persists after SES; extends long-term observational data on predictors but leaves open need for prospective validation.
Late target lesion revascularization after sirolimus-eluting stent implantation continues at a steady rate of approximately 2.1% per year up to 5 years, strongly predicted by insulin-treated diabetes and stent fracture.
Hara et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: